Pre-market
Loading markets…

Advertisement

PARTNER SPOTLIGHT

CIBC Investor's Edge

Get 200 free trades when you open an eligible CIBC Investor's Edge account.

  • ✓200 free stock & ETF trades
  • ✓Unlimited commission-free trades on 180+ select ETFs
  • ✓Offer ends September 30, 2026
Stocks/NASDAQ/NXL

Nexalin Technology Inc. (NXL : NASDAQ)

Common Stock

$7.55

USD

+3.27 (76.40%)

Last updated: 2026-10-01

Follow NXL

NXL

Nexalin Technology Inc.

Source:WealthAwesomeWealthAwesome
↓ $2.38 (-23.97%)
30 day period
$4.27$7.12$9.96Aug 20Sep 11Oct 1

Performance

1 Day

+76.40%

1 Week

+73.38%

1 Month

+11.03%

YTD

-35.96%

Key Statistics

Market Cap

$6.26M

52W High

$60.00

52W Low

$4.00

P/E Ratio

-

50 Day MA

$8.11

200 Day MA

$12.93

Beta

3.98

Dividend Yield

-

Advertisement

Technical Indicators

Price vs 50-Day SMA

↓Below 50 SMA

Price vs 200-Day SMA

↓Below 200 SMA

Recent Price History

DateOpenHighLowCloseAdj CloseVolume
10/1/2026$8.80$10.98$6.80$7.55$7.5562,336,586
9/30/2026$4.48$4.50$4.10$4.28$4.287,053
9/29/2026$4.60$5.31$4.35$4.35$4.3564,530
9/28/2026$4.50$4.53$4.10$4.27$4.275,511
9/25/2026$4.39$4.39$4.39$4.39$4.392,200
9/24/2026$4.96$5.02$4.30$4.35$4.3510,234
9/23/2026$4.61$5.09$4.61$4.81$4.816,995
9/22/2026$4.40$4.63$4.31$4.63$4.6313,328
9/21/2026$4.80$5.14$4.00$4.27$4.2711,967
9/18/2026$5.06$5.36$4.73$4.90$4.9015,000

Analyst Price Targets

Based on 1 analyst covering NXL · as of Sep 17, 2026

📈

Wall Street analysts forecast NXL stock price to rise 694.7% over the next 12 months.

Consensus

Buy

4.00 / 5.00

Avg. Target

US$60.00

+694.7% Upside

Current Price

US$7.55

Last close

Analyst Breakdown (1 analysts)

Buy 1
Compare analyst targets →

Targets are snapshotted when they change. Unchanged figures keep their original date. Not financial advice.

Wealth Awesome Price Forecast

WA Model

Statistical 90-day price range based on NXL's historical volatility

HistoricalForecast68%95%
US$0.59US$13.91US$27.22US$40.54US$53.85US$67.17TodayJun 17Aug 11Oct 1Nov 13Dec 27Feb 8

30-Day Vol

195.3%

Annualized

90-Day Vol

152.3%

Annualized

Trend (90d)

-50.0%

Annualized drift

90d Mean

US$6.32

Expected price

HorizonExpected68% Range (1σ)
30 trading daysUS$7.11US$3.63 – US$13.96
60 trading daysUS$6.70US$2.58 – US$17.39
90 trading daysUS$6.32US$1.97 – US$20.29

Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.

About Nexalin Technology Inc.

Nexalin Technology, Inc., a medical device company, designs and develops neurostimulation products for the treatment of mental health epidemic in the United States and China. The company offers Generation 1, an easy-to-administer medical device which utilizes bioelectronic medical technology to treat anxiety, insomnia, and depression without the need for drugs or psychotherapy; and Generation 2 and Generation 3 headset devices for the treatment of depression, substance use disorder, traumatic brain injury, post-traumatic stress disorder, opioid addiction, alcoholism, and chronic pain, as well as alzheimer's disease, and dementia. Nexalin Technology, Inc. is headquartered in Houston, Texas.

Financials

Revenue (TTM)
$217,155
EBITDA
$-9.08M
Profit Margin
0.00%
ROE (TTM)
-240.25%
EPS (Diluted)
-24.34
Book Value
2.07

Classification

Sector
Health Care
Industry
Health Care Equipment & Supplies
Group
Health Care Equipment & Services

7 stocks to buy and hold forever

Blue-chip dividend stocks for long-term wealth building.

Get the FREE Report

Advertisement

Common Questions About NXL.US

Market movers

Recent NASDAQ movers

Top 1-day gainers — updated from our Canadian movers feed.

All movers →
TickerNamePrice1D
IFRXInflaRx N.V.$145.00+7955.56%
BGMQilian International Holding Group Limited$7.82+3005.64%
KUSTKustom Entertainment, Inc.$4.42+944.42%
SSMSono Group N.V.$2.21+97.32%
VEEAVeea Inc.$3.47+59.91%
RPGLRepublic Power Group Limited Class A Ordinary Shares$26.20+59.85%
XRPNArmada Acquisition Corp. II$23.43+42.87%
AFJKRAimei Health Technology Co., Ltd Right$0.12+37.82%

Advertisement